Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
This grant funds innovative technologies and platforms that enhance research in heart, lung, blood, and sleep (HLBS) disorders.
About this program
The Catalyze grant program aims to support the development of enabling technologies and transformative platforms that can significantly advance research in heart, lung, blood, and sleep (HLBS) disorders. This initiative is designed for researchers and organizations focused on creating novel solutions that address critical challenges in HLBS research. By fostering innovation in this area, the program seeks to improve health outcomes and enhance the understanding of these vital systems. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in HLBS research. The grant encourages collaboration among researchers, technology developers, and healthcare professionals to create impactful tools and methodologies. The program does not allow clinical trials, focusing instead on the foundational technologies that can lead to future clinical applications.
Eligibility
Academic institutions, nonprofit organizations, and other entities engaged in HLBS research.